Edward Bloomberg - HealthEquity COO, Executive Vice President

HQY Stock  USD 81.63  1.91  2.40%   

President

Mr. Edward Bloomberg was appointed Chief Operating Officer, Executive Vice President of the Company effective as of August 13, 2018. He was most recently Senior Vice President of Operations, Strategy and Support for Financial Engines, Inc. from January 2016 to June 2018, where he coled the integration of Financial Engines, Inc.s acquisition of The Mutual Fund Store, and served as the head of strategy, back office operations, and as a member of the Operating Committee. Prior to that, Mr. Bloomberg was the Chief Operating Officer of The Mutual Fund Store, LLC from July 2012 until its acquisition by Financial Engines, Inc. in January 2016. Prior to joining The Mutual Fund Store, LLC, Mr. Bloomberg served in various capacities of leadership at TD Ameritrade Holding Corporation from 2002 to June 2012, with his most recent position as the managing director of Investools, Inc., the education subsidiary of TD Ameritrade Holding Corporation since 2018.
Age 41
Tenure 6 years
Address 15 West Scenic Pointe Drive, Draper, UT, United States, 84020
Phone801 727 1000
Webhttps://www.healthequity.com
Bloomberg holds a BS degree in Industrial & Labor Relations from Cornell University.

HealthEquity Management Efficiency

The company has Return on Asset of 0.0256 % which means that on every $100 spent on assets, it made $0.0256 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0284 %, implying that it generated $0.0284 on every 100 dollars invested. HealthEquity's management efficiency ratios could be used to measure how well HealthEquity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.04 in 2024. Return On Assets is likely to drop to 0.02 in 2024. At this time, HealthEquity's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 51 M in 2024, whereas Other Assets are likely to drop 0.95 in 2024.
The company has 933.14 M in debt with debt to equity (D/E) ratio of 0.54, which is OK given its current industry classification. HealthEquity has a current ratio of 2.41, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist HealthEquity until it has trouble settling it off, either with new capital or with free cash flow. So, HealthEquity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like HealthEquity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for HealthEquity to invest in growth at high rates of return. When we think about HealthEquity's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Jenifer GohEUDA Health Holdings
34
Michael KimMultiPlan
57
Jonathan FaddisVeeva Systems Class
52
Josh FaddisVeeva Systems Class
42
John BuregaSo Young International
N/A
Jenifer GohEUDA Health Holdings
34
Shannon McShaneReedSo Young International
N/A
Alan MateoVeeva Systems Class
62
Jim HeadMultiPlan
55
James HeadMultiPlan
58
Frederic LequientVeeva Systems Class
51
Jonathan ArangoMangoceuticals Common Stock
29
Nakade RyoshinEtao International Co
53
David RedmondMultiPlan
68
Thomas SchwengerVeeva Systems Class
56
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people. HealthEquity (HQY) is traded on NASDAQ Exchange in USA. It is located in 15 West Scenic Pointe Drive, Draper, UT, United States, 84020 and employs 3,126 people. HealthEquity is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

HealthEquity Leadership Team

Elected by the shareholders, the HealthEquity's board of directors comprises two types of representatives: HealthEquity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HealthEquity. The board's role is to monitor HealthEquity's management team and ensure that shareholders' interests are well served. HealthEquity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HealthEquity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthew Sydney, Executive VP of Sales and Marketing
Frode Jensen, Executive Vice President - General council and secretery
Robert Selander, Non-Executive Chairman of the Board
Evelyn Dilsaver, Independent Director
Edward Bloomberg, COO, Executive Vice President
Adrian Dillon, Director
William Otten, Executive Vice President of Sales
Larry Trittschuh, Executive Vice President Chief Security Officer
Jon Kessler, CEO and President and Director
Stephen Neeleman, Vice Chairman of the Board, Founder
Delano Ladd, Executive Vice President General Counsel and Corporate Secretary
Jon Soldan, Executive VP of Operations
Debra McCowan, Director
Frank Corvino, Independent Director
Manu Rana, Independent Director
Gary Robinson, Executive Vice President Chief Marketing Officer
Elimelech Rosner, Executive CTO
Tia Padia, Executive Officer
Richard Putnam, IR Contact Officer
James Lucania, CFO VP
Ian Sacks, Independent Director
Angelique Hill, Executive Vice President - Operations
Michael Leavitt, Independent Director
Darcy Mott, CFO, Executive VP and Treasurer
Gayle Wellborn, Director
Brad Bennion, Senior Development
Tyson Murdock, Ex CFO
Jonathan Soldan, Executive Vice President - Operations
Steve Lindsay, Executive Management
Frank Medici, Independent Director
Ashley Dreier, Executive Vice President CTO and CIO

HealthEquity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HealthEquity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for HealthEquity Stock analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
0.64
Revenue Per Share
11.682
Quarterly Revenue Growth
0.122
Return On Assets
0.0256
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.